Ledger.Open graph →
SEC Form D · Amendment · filed April 11, 2024

Praesidia Biotherapeutics, Inc

Offering
$15.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ARLINGTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Shawn Titcomb · Lauderdale by the Sea, FLDirectorMartin Lehr · Arlington, MADirectorPradip Majumder · Arlington, MAExecSohang Chatterjee · Arlington, MAExec · DirectorClayton M. Olson · VANCOUVER, British Columbia, CanadaExecMartin Lehr · Arlington, MADirectorDal C. Reid · Amarillo, TXExec · DirectorDouglas J. Crozier · Amarillo, TXDirectorCurtis A. Lockshin · Marlborough, MAExecRobert J. Bitterman · Marlborough, MADirectorRobert A. Ferrara · Marlborough, MAExec · DirectorKeith E. Pyne · Vancouver, British Columbia, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗